Chiffres calculés à partir des déclarations réglementaires officielles — .
Détentioninitiés 11.42% · institutions 72.21%
En EUR · au Oct 19, 2026
Interroger la machine
Recherchez et comparez les opérations d’initiés, les sociétés et leurs statistiques en langage courant. Votre question devient une requête sur les données disponibles, pas une conversation ni un conseil en investissement.
Données de Gerresheimer AG uniquement. Pas de recherche web. Les statistiques globales d’un initié sont exclues.
Une recherche exécutée consomme un crédit, même sans résultat. Les erreurs et les questions non prises en charge ne consomment rien.
Gerresheimer AG, together with its subsidiaries, provides drug containment solutions in Germany and internationally. The company operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. It offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and containers, bottles, caps, closures, applicators, and accessories; development, industrialization, and contract manufacturing of drug delivery programs; project and quality management; and drug delivery devices, including inhalers, injection/auto injectors, and pen injectors. The company also provides diagnostic and medical devices comprising point-of-care tests, laboratory disposables, chemical and technical bottles, diagnostic and polymer vials, dropper bottles, PET bottles, and medical products comprising lancing devices, infusion sets, and disposable systems. In addition, it offers cosmetic packaging solutions, such as moulded glass flacons and jars; tubular glass ampoules, droppers, samplers and vials; and plastic packaging products, as well as pharmaceutical, laboratory, and regulatory affairs services. The company offers its products to pharmacy chains, supermarkets, and wholesalers. The company serves pharma, biotech, medical technology, diagnostics, cosmetics, glass containers, and food and beverage industries. Gerresheimer AG was founded in 1864 and is based in Düsseldorf, Germany.
Source des informations de marché · Oct 19, 2026
Chronologie sur le marché · historique complet
18 achats— cours de clôturebarre = volume usd, échelle √cliquez sur une période pour filtrer le tableau
| Initié | Type | Valeur · USD | Signaux | Détail |
|---|---|---|---|---|
| Active Ownership Opportunities SCS | Achat | $150.3K | conv 6 |
| Active Ownership Opportunities SCS | Achat | $2.5M | conv 7 | BAFIN |
| Active Ownership Opportunities SCS | Achat | $128.6K | conv 9 | BAFIN |
| Active Ownership Opportunities SCS | Achat | $915.9K | conv 6 | BAFIN |
| Active Ownership Opportunities SCS | Achat | $294.4K | conv 6 | BAFIN |
| Active Ownership Opportunities SCS | Achat | $2.4M | conv 9 | BAFIN |
| Active Ownership Opportunities SCS | Achat | $8M | conv 23Premier en 12 mois | BAFIN |
| AOC Gecko S.à r.l.historique | Achat | $9M | conv 17 | BAFIN |
| Active Ownership Fund SICAV SIF SCShistorique | Achat | $3M | conv 17 | BAFIN |
| Active Ownership Fund SICAV SIF SCShistorique | Achat | $1.1M | conv 9 | BAFIN |
| AOC Gecko S.à r.l.historique | Achat | $3.4M | conv 9 | BAFIN |
| AOC Gecko S.à r.l.historique | Achat | $3.7M | conv 9 | BAFIN |
| Active Ownership Fund SICAV SIF SCShistorique | Achat | $477K | conv 6 | BAFIN |
| Active Ownership Fund SICAV SIF SCShistorique | Achat | $1.2M | conv 9 | BAFIN |
| AOC Gecko S.à r.l.historique | Achat | $1.4M | conv 6 | BAFIN |
| AOC Gecko S.à r.l.historique | Achat | $11.2M | conv 51Premier en 12 mois | BAFIN |
| Active Ownership Fund SICAV SIF SCShistorique | Achat | $3.7M | conv 56Premier en 12 mois | BAFIN |
| Dietmar Siemssen | Achat | $67.9K | conv 64Premier en 12 mois | BAFIN |